---
title: "AbbVie Inc. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289099978.md"
description: "AbbVie Inc. (ABBV) shares fell 1.83% to $223.07 on Monday, snapping a four-day winning streak and underperforming competitors like Johnson & Johnson, Pfizer, and Amgen. The decline occurred during a mixed market session where the S&P 500 rose slightly while the Dow Jones dipped. AbbVie closed 8.88% below its 52-week high of $244.81 set in October. Trading volume was lower than the 50-day average."
datetime: "2026-06-08T20:31:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289099978.md)
  - [en](https://longbridge.com/en/news/289099978.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289099978.md)
---

# AbbVie Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) slid 1.83% to $223.07 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.30% to 7,405.73 and the Dow Jones Industrial Average falling 0.16% to 50,786.01.

The stock's fall snapped a four-day winning streak.

AbbVie Inc. closed 8.88% below its 52-week high of $244.81, which the company achieved on October 1st.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.26% to $232.16, Pfizer Inc. (PFE) fell 1.61% to $25.62, and Amgen Inc. (AMGN) fell 1.10% to $345.73.

Trading volume (4.8 M) remained 1.4 million below its 50-day average volume of 6.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 8, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-08-26 1631ET

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026 | ABBV Stock News](https://longbridge.com/en/news/289051772.md)
- [AbbVie Inc. $ABBV Shares Acquired by Capital International Investors](https://longbridge.com/en/news/288952829.md)
- [Saturna Capital Corp Purchases 31,143 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/289451855.md)
- [Assessing AbbVie (ABBV) Valuation After Fresh Regulatory Wins In Migraine And Blood Cancer](https://longbridge.com/en/news/288933137.md)
- [AbbVie Targets Tough Pancreatic Cancer With New Phase 2/3 Telisotuzumab Study](https://longbridge.com/en/news/289622599.md)